Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4554149
Max Phase: Preclinical
Molecular Formula: C11H11Cl2N
Molecular Weight: 228.12
Molecule Type: Unknown
Associated Items:
ID: ALA4554149
Max Phase: Preclinical
Molecular Formula: C11H11Cl2N
Molecular Weight: 228.12
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C#CCN(C)Cc1c(Cl)cccc1Cl
Standard InChI: InChI=1S/C11H11Cl2N/c1-3-7-14(2)8-9-10(12)5-4-6-11(9)13/h1,4-6H,7-8H2,2H3
Standard InChI Key: BNTPRFUNFJNCJB-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 228.12 | Molecular Weight (Monoisotopic): 227.0269 | AlogP: 3.06 | #Rotatable Bonds: 3 |
Polar Surface Area: 3.24 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 5.78 | CX LogP: 3.35 | CX LogD: 3.34 |
Aromatic Rings: 1 | Heavy Atoms: 14 | QED Weighted: 0.72 | Np Likeness Score: -1.54 |
1. Milne K, Sun J, Zaal EA, Mowat J, Celie PHN, Fish A, Berkers CR, Forlani G, Loayza-Puch F, Jamieson C, Agami R.. (2019) A fragment-like approach to PYCR1 inhibition., 29 (18): [PMID:31362921] [10.1016/j.bmcl.2019.07.047] |
Source(1):